Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview
Abstract In December 2019, Coronavirus Disease 2019 (COVID-19) was reported in Wuhan,
China. Comprehensive strategies for quick identification, prevention, control, and remedy of …
China. Comprehensive strategies for quick identification, prevention, control, and remedy of …
Epidemic efficacy of Covid-19 vaccination against Omicron: An innovative approach using enhanced residual recurrent neural network
R Kumar, M Gupta, A Agarwal, A Mukherjee… - Plos one, 2023 - journals.plos.org
The outbreak of COVID-19 has engulfed the entire world since the end of 2019, causing
tremendous loss of lives. It has also taken a toll on the healthcare sector due to the inability …
tremendous loss of lives. It has also taken a toll on the healthcare sector due to the inability …
SARS-CoV-2 before and after Omicron: two different viruses and two different diseases?
R Gili, R Burioni - Journal of translational medicine, 2023 - Springer
For the first time in the history of medicine, it has been possible to describe—after a spillover—
the evolution of a new human virus spreading in a non-immune population. This allowed not …
the evolution of a new human virus spreading in a non-immune population. This allowed not …
Interaction of SARS-CoV-2 with host cells and antibodies: experiment and simulation
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the devastating global COVID-19 pandemic announced by WHO in March 2020. Through …
the devastating global COVID-19 pandemic announced by WHO in March 2020. Through …
The Delta and Omicron variants of SARS-CoV-2: what we know so far
The world has not yet completely overcome the fear of the havoc brought by SARS-CoV-2.
The virus has undergone several mutations since its initial appearance in China in …
The virus has undergone several mutations since its initial appearance in China in …
[HTML][HTML] COVID-19 vaccination and BA. 1 breakthrough infection induce neutralising antibodies which are less efficient against BA. 4 and BA. 5 Omicron variants …
L Kliker, N Zuckerman, N Atari, N Barda… - …, 2022 - eurosurveillance.org
This work evaluated neutralising antibody titres against wild type (WT) SARS-CoV-2 and
four Omicron variants (BA. 1, BA. 2, BA. 4 and BA. 5) in healthcare workers who had …
four Omicron variants (BA. 1, BA. 2, BA. 4 and BA. 5) in healthcare workers who had …
[HTML][HTML] Community resilience in city emergency: Exploring the roles of environmental perception, social justice and community attachment in subjective well-being of …
Despite the importance of social justice and community attachment for subjective well-being
(SWB), the existing research fails to adequately examine these factors in urban …
(SWB), the existing research fails to adequately examine these factors in urban …
Meta-analysis of 16S rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases
X Cheng, Y Zhang, Y Li, Q Wu, J Wu, SK Park, C Guo… - BMC microbiology, 2022 - Springer
Background Dozens of studies have demonstrated gut dysbiosis in COVID-19 patients
during the acute and recovery phases. However, a consensus on the specific COVID-19 …
during the acute and recovery phases. However, a consensus on the specific COVID-19 …
SARS-CoV-2 omicron (B. 1.1. 529) variant: a challenge with COVID-19
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there have
been multiple peaks of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus …
been multiple peaks of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus …
Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalization
Q Wang, SB Ye, ZJ Zhou, AL Song… - Journal of Medical …, 2023 - Wiley Online Library
To control the ongoing COVID‐19 pandemic, a variety of severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) vaccines have been developed. However, the rapid mutations …
coronavirus 2 (SARS‐CoV‐2) vaccines have been developed. However, the rapid mutations …